Rapidly Detachable Microneedles Using Porous Water‐Soluble Layer for Ocular Drug Delivery

Detachable microneedle (MN) technology is highly desired for treatment of ocular diseases such as keratitis or glaucoma because of its minimally invasiveness and sustained drug delivery. However, shortening of administration time during insertion into target tissues still remains an important issue, although various approaches using mechanical and chemical separation mechanisms have been attempted. Here, a rapidly detachable microneedle pen (RD‐MNP) containing a porous dissolvable sacrificial layer is fabricated for instant separation of the tip. The porous sacrificial layer is fabricated between a drug‐loaded tip and a base by freeze drying. The sacrificial layer is comprised of water soluble polymers: poly(vinyl alcohol) (PVA) and poly(vinyl pyrrolidone) (PVP). Porous structure can accelerate dissolution rate compared to solid structure due to its capillary effect that relies on pore size and distribution. The pore size and distribution of the sacrificial layer are controlled and detachment of an RD‐MNP with the optimum pore structures is immediate upon dipping the MNP in PBS. Furthermore, the insertion characteristics of the system are investigated using the gelatin phantom and porcine eye sclera. With the optimized sacrificial layer, a MN tip is almost immediately detached and embedded to the porcine sclera with the aid of impact insertion.

[1]  M. Prausnitz,et al.  Rapidly separable microneedle patch for the sustained release of a contraceptive , 2019, Nature Biomedical Engineering.

[2]  Chang Sik Cho,et al.  Depthwise‐controlled scleral insertion of microneedles for drug delivery to the back of the eye , 2018, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[3]  Chenjie Xu,et al.  Self-implantable double-layered micro-drug-reservoirs for efficient and controlled ocular drug delivery , 2018, Nature Communications.

[4]  WonHyoung Ryu,et al.  Intracorneal injection of a detachable hybrid microneedle for sustained drug delivery. , 2018, Acta biomaterialia.

[5]  Seong-O Choi,et al.  Immediate separation of microneedle tips from base array during skin insertion for instantaneous drug delivery , 2018, RSC advances.

[6]  H. McCarthy,et al.  Rapidly dissolving polymeric microneedles for minimally invasive intraocular drug delivery , 2016, Drug Delivery and Translational Research.

[7]  Q. Wei,et al.  Measurement and modeling of the effect of composition ratios on the properties of poly(vinyl alcohol)/poly(vinyl pyrrolidone) membranes , 2016 .

[8]  Szu-Yin Chen The effect of pore size and porosity on capillary pressure in microporous hydroxyapatite samples , 2015 .

[9]  Hyun Beom Song,et al.  Impact insertion of transfer-molded microneedle for localized and minimally invasive ocular drug delivery. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[10]  M. Prausnitz,et al.  Targeted delivery of antiglaucoma drugs to the supraciliary space using microneedles. , 2014, Investigative ophthalmology & visual science.

[11]  G. Campbell,et al.  Indentation and needle insertion properties of the human eye , 2014, Eye.

[12]  David C. Yeo,et al.  Drug-eluting microneedles for self-administered treatment of keloids , 2014 .

[13]  A. Murakami,et al.  Effect of long-term treatment with eyedrops for glaucoma on conjunctival bacterial flora , 2011, Infection and drug resistance.

[14]  S. Kotak,et al.  Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review , 2011, Patient preference and adherence.

[15]  M. Garland,et al.  Microneedle arrays as medical devices for enhanced transdermal drug delivery , 2011, Expert review of medical devices.

[16]  L. Qian,et al.  Controlled freezing and freeze drying: a versatile route for porous and micro‐/nano‐structured materials , 2011 .

[17]  M. Blumenkranz,et al.  Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. , 2010, Ophthalmology.

[18]  D. Bikiaris,et al.  Dissolution rate enhancement of the poorly water-soluble drug Tibolone using PVP, SiO2, and their nanocomposites as appropriate drug carriers , 2009, Drug development and industrial pharmacy.

[19]  Mark R. Prausnitz,et al.  Intrascleral Drug Delivery to the Eye Using Hollow Microneedles , 2009, Pharmaceutical Research.

[20]  H. Zhang,et al.  Aligned Porous Structures by Directional Freezing , 2007 .

[21]  Eduardo Saiz,et al.  Ice-templated porous alumina structures , 2007, 1710.04651.

[22]  Louise E. Smith,et al.  Examination of the effects of poly(N-vinylpyrrolidinone) hydrogels in direct and indirect contact with cells. , 2006, Biomaterials.

[23]  C. Alvarez‐Lorenzo,et al.  Timolol uptake and release by imprinted soft contact lenses made of N,N-diethylacrylamide and methacrylic acid. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[24]  B. Tengroth,et al.  Blindness in glaucoma patients. , 2009, Acta ophthalmologica Scandinavica.

[25]  A. Urtti,et al.  Controlled drug delivery devices for experimental ocular studies with timolol 2. Ocular and systemic absorption in rabbits , 1990 .

[26]  D. Pavan-Langston,et al.  Pilocarpine ocusert system for sustained control of ocular hypertension. , 1975, Archives of ophthalmology.